Trial intelligence / Profile preview

Nesiritide in CABG patients with heart failure

NCT00653042Phase 2Completed

Sponsor
Scios Inc.
Start
Mar 2004
Modality
Recombinant Proteins and Enzymes
01

Overview

A Phase 2 trial of nesiritide in heart failure (HF), acute kidney injury (AKI), sponsored by Scios Inc.. Started Mar 2004; status: completed.

02

Drugs

nesiritide
03

Conditions

heart failure (HF)acute kidney injury (AKI)

Beyond the preview

Go deeper on NCT00653042.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00653042.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call